We've found
2,200 HIV / AIDS
clinical trials
We've found
2,200 HIV / AIDS
clinical trials
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Updated: 1/12/2017
Pericardial Fat and Inflammation in HIV Patients and Controls
Status: Enrolling
Updated: 1/12/2017
Click here to add this to my saved trials

HIV Medication Adherence Clinical Trial
Updated: 1/8/2018
Supporting Treatment Adherence Readiness Through Training (START)
Status: Enrolling
Updated: 1/8/2018
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
Early Infant HIV Treatment in Botswana
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Immunology / Infectious Diseases, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Immunology / Infectious Diseases, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Immunology / Infectious Diseases, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Human Immunodeficiency Virus (HIV) Prophylaxis Clinical Trial
Updated: 3/4/2016
Safety and Pharmacokinetic Study of HIV Prophylaxis Using Antiretroviral Intravaginal Rings in Healthy Women
Status: Enrolling,
Phase
Updated: 3/4/2016
Click here to add this to my saved trials

HIV Clinical Trial
Updated: 3/10/2016
Sleep and Cognition After Atripla to Stribild Switch
Status: Enrolling,
Phase
IV
Updated: 3/10/2016
Click here to add this to my saved trials

Immunology / Infectious Diseases, Oncology Clinical Trial
Updated: 9/29/2017
Safety Study of Gene Modified Donor T-cells Following TCR Alpha Beta Depleted Stem Cell Transplant
Status: Enrolling,
Phase
I, II
Updated: 9/29/2017
Click here to add this to my saved trials

Immunology / Infectious Diseases, Oncology Clinical Trial
Updated: 9/29/2017
Safety Study of Gene Modified Donor T-cells Following TCR Alpha Beta Depleted Stem Cell Transplant
Status: Enrolling,
Phase
I, II
Updated: 9/29/2017
Click here to add this to my saved trials

Immunology / Infectious Diseases, Oncology Clinical Trial
Updated: 9/29/2017
Safety Study of Gene Modified Donor T-cells Following TCR Alpha Beta Depleted Stem Cell Transplant
Status: Enrolling,
Phase
I, II
Updated: 9/29/2017
Click here to add this to my saved trials

HIV INfections Clinical Trial
Updated: 12/31/1969
Evaluating the Safety and Pharmacokinetics of VRC01, VRC01LS, and VRC07-523LS, Potent Anti-HIV Neutralizing Monoclonal Antibodies, in HIV-1-Exposed Infants
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

HIV INfections Clinical Trial
Updated: 12/31/1969
Evaluating the Safety and Pharmacokinetics of VRC01, VRC01LS, and VRC07-523LS, Potent Anti-HIV Neutralizing Monoclonal Antibodies, in HIV-1-Exposed Infants
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

HIV Clinical Trial
Updated: 11/5/2014
PRO 140 for Human Immunodeficiency Virus Infection
Status: Enrolling,
Phase
II
Updated: 11/5/2014
Click here to add this to my saved trials

Immunology / Infectious Diseases Clinical Trial
Updated: 3/8/2017
Behavioral Consultation for HIV+ Older Adults Prescribed Opioids for Chronic Pain
Status: Enrolling
Updated: 3/8/2017
Click here to add this to my saved trials

HIV Clinical Trial
Updated: 3/22/2016
Ibalizumab Plus Optimized Background Regimen in Patient With Multi-Drug Resistant HIV
Status: Enrolling,
Phase
III
Updated: 3/22/2016
Click here to add this to my saved trials

HIV Clinical Trial
Updated: 3/22/2016
Ibalizumab Plus Optimized Background Regimen in Patient With Multi-Drug Resistant HIV
Status: Enrolling,
Phase
III
Updated: 3/22/2016
Click here to add this to my saved trials

HIV Clinical Trial
Updated: 3/22/2016
Ibalizumab Plus Optimized Background Regimen in Patient With Multi-Drug Resistant HIV
Status: Enrolling,
Phase
III
Updated: 3/22/2016
Click here to add this to my saved trials

HIV Clinical Trial
Updated: 3/22/2016
Ibalizumab Plus Optimized Background Regimen in Patient With Multi-Drug Resistant HIV
Status: Enrolling,
Phase
III
Updated: 3/22/2016
Click here to add this to my saved trials

HIV Clinical Trial
Updated: 3/22/2016
Ibalizumab Plus Optimized Background Regimen in Patient With Multi-Drug Resistant HIV
Status: Enrolling,
Phase
III
Updated: 3/22/2016
Click here to add this to my saved trials

HIV Clinical Trial
Updated: 3/22/2016
Ibalizumab Plus Optimized Background Regimen in Patient With Multi-Drug Resistant HIV
Status: Enrolling,
Phase
III
Updated: 3/22/2016
Click here to add this to my saved trials

HIV Clinical Trial
Updated: 3/22/2016
Ibalizumab Plus Optimized Background Regimen in Patient With Multi-Drug Resistant HIV
Status: Enrolling,
Phase
III
Updated: 3/22/2016
Click here to add this to my saved trials

HIV Clinical Trial
Updated: 3/22/2016
Ibalizumab Plus Optimized Background Regimen in Patient With Multi-Drug Resistant HIV
Status: Enrolling,
Phase
III
Updated: 3/22/2016
Click here to add this to my saved trials

HIV Clinical Trial
Updated: 3/22/2016
Ibalizumab Plus Optimized Background Regimen in Patient With Multi-Drug Resistant HIV
Status: Enrolling,
Phase
III
Updated: 3/22/2016
Click here to add this to my saved trials

HIV Clinical Trial
Updated: 12/31/1969
The Georgia Latino AIDS/HIV Diagnosis and Linkage in Youth (GLADLY) Project
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Immunology / Infectious Diseases, Psychiatry / Psychology Clinical Trial
Updated: 12/31/1969
ARCH II Study (Alcohol Research Center on HIV Study II)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

HIV Clinical Trial
Updated: 10/23/2015
Development of Adherence Biomarkers for Multiple Microbicide and Multipurpose Prevention Technology (MPT) Dosage Forms
Status: Enrolling,
Phase
I
Updated: 10/23/2015
Click here to add this to my saved trials

Immunology / Infectious Diseases, Oncology Clinical Trial
Updated: 12/31/1969
Pembrolizumab in Treating Patients With HIV and Relapsed, Refractory, or Disseminated Malignant Neoplasms
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

HIV Infection Clinical Trial
Updated: 12/31/1969
Observational Study of HIV+ Deceased Donor Transplant for HIV+ Recipients
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

HIV Infection Clinical Trial
Updated: 12/31/1969
Observational Study of HIV+ Deceased Donor Transplant for HIV+ Recipients
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Primary Immunodeficiency Diseases (PID) Clinical Trial
Updated: 12/31/1969
Non-Interventional Post-Marketing Safety Study on the Long-Term Safety of HYQVIA (Global)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Primary Immunodeficiency Diseases (PID) Clinical Trial
Updated: 12/31/1969
Non-Interventional Post-Marketing Safety Study on the Long-Term Safety of HYQVIA (Global)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Primary Immunodeficiency Diseases (PID) Clinical Trial
Updated: 12/31/1969
Non-Interventional Post-Marketing Safety Study on the Long-Term Safety of HYQVIA (Global)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Primary Immunodeficiency Diseases (PID) Clinical Trial
Updated: 12/31/1969
Non-Interventional Post-Marketing Safety Study on the Long-Term Safety of HYQVIA (Global)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Primary Immunodeficiency Diseases (PID) Clinical Trial
Updated: 12/31/1969
Non-Interventional Post-Marketing Safety Study on the Long-Term Safety of HYQVIA (Global)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Primary Immunodeficiency Diseases (PID) Clinical Trial
Updated: 12/31/1969
Non-Interventional Post-Marketing Safety Study on the Long-Term Safety of HYQVIA (Global)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Primary Immunodeficiency Diseases (PID) Clinical Trial
Updated: 12/31/1969
Non-Interventional Post-Marketing Safety Study on the Long-Term Safety of HYQVIA (Global)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
Healing Hearts and Mending Minds in Older Adults Living With HIV
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
Mobile Health Application to Improve HIV Medication Adherence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

HIV/AIDS Clinical Trial
Updated: 1/15/2016
Effectiveness of Peer Navigation and Contingency Management on Retention in HIV Care
Status: Enrolling
Updated: 1/15/2016
Click here to add this to my saved trials

HIV/AIDS Clinical Trial
Updated: 1/15/2016
Effectiveness of Peer Navigation and Contingency Management on Retention in HIV Care
Status: Enrolling
Updated: 1/15/2016
Click here to add this to my saved trials

Human Immunodeficiency Virus Clinical Trial
Updated: 3/28/2017
Cooperative Re-Engagement Controlled Trial (CoRECT)
Status: Enrolling
Updated: 3/28/2017
Click here to add this to my saved trials

Immunology / Infectious Diseases, Psychiatry / Psychology Clinical Trial
Updated: 12/31/1969
Effectiveness of Nurse-delivered Care for Adherence/Mood in HIV in South Africa
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Immunology / Infectious Diseases, Oncology Clinical Trial
Updated: 12/31/1969
Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

Immunology / Infectious Diseases, Oncology Clinical Trial
Updated: 12/31/1969
Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

HIV INfections Clinical Trial
Updated: 12/31/1969
Safety and Efficacy Study of Injectable Cabotegravir Compared to Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC), For Pre-Exposure Prophylaxis in HIV-Uninfected Cisgender Men and Transgender Women Who Have Sex With Men
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

HIV INfections Clinical Trial
Updated: 12/31/1969
Safety and Efficacy Study of Injectable Cabotegravir Compared to Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC), For Pre-Exposure Prophylaxis in HIV-Uninfected Cisgender Men and Transgender Women Who Have Sex With Men
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

HIV INfections Clinical Trial
Updated: 12/31/1969
Safety and Efficacy Study of Injectable Cabotegravir Compared to Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC), For Pre-Exposure Prophylaxis in HIV-Uninfected Cisgender Men and Transgender Women Who Have Sex With Men
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

HIV INfections Clinical Trial
Updated: 12/31/1969
Safety and Efficacy Study of Injectable Cabotegravir Compared to Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC), For Pre-Exposure Prophylaxis in HIV-Uninfected Cisgender Men and Transgender Women Who Have Sex With Men
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

HIV INfections Clinical Trial
Updated: 12/31/1969
Safety and Efficacy Study of Injectable Cabotegravir Compared to Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC), For Pre-Exposure Prophylaxis in HIV-Uninfected Cisgender Men and Transgender Women Who Have Sex With Men
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

HIV INfections Clinical Trial
Updated: 12/31/1969
Safety and Efficacy Study of Injectable Cabotegravir Compared to Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC), For Pre-Exposure Prophylaxis in HIV-Uninfected Cisgender Men and Transgender Women Who Have Sex With Men
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

HIV INfections Clinical Trial
Updated: 12/31/1969
Evaluating the Safety and Pharmacokinetics of Maraviroc in HIV-1-Exposed Infants at Risk of Acquiring HIV-1 Infection
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

HIV-1 Infection Clinical Trial
Updated: 12/31/1969
Biomarkers to Predict Time to Plasma HIV RNA Rebound
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

HIV-1 Infection Clinical Trial
Updated: 12/31/1969
Early ART to Limit Infection and Establishment of Reservoir
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

HIV-1 Infection Clinical Trial
Updated: 12/31/1969
Early ART to Limit Infection and Establishment of Reservoir
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

HIV-1 Infection Clinical Trial
Updated: 12/31/1969
Early ART to Limit Infection and Establishment of Reservoir
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

HIV Clinical Trial
Updated: 1/8/2016
Analytic Treatment Interruption (ATI) to Assess HIV Cure
Status: Enrolling
Updated: 1/8/2016
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
Mechanisms of Diastolic Dysfunction Among Persons With HIV Compared With Non-HIV Control Subjects
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
CCTG 603: Randomized Controlled Trial of iTAB Plus Motivational Interviewing for PrEP Adherence in Transgender Individuals (The iM-PrEPT Study)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
CCTG 603: Randomized Controlled Trial of iTAB Plus Motivational Interviewing for PrEP Adherence in Transgender Individuals (The iM-PrEPT Study)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Immunology / Infectious Diseases, Neurology, Psychiatry / Psychology Clinical Trial
Updated: 12/31/1969
Intranasal Insulin for the Treatment of HAND
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

HIV-1 Infection Clinical Trial
Updated: 12/31/1969
Biomarkers to Predict Time to Plasma HIV RNA Rebound
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

HIV-1 Infection Clinical Trial
Updated: 12/31/1969
Biomarkers to Predict Time to Plasma HIV RNA Rebound
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

HIV INfections Clinical Trial
Updated: 12/31/1969
Connecting Youth and Young Adults to Optimize ART Adherence: YouTHrive Efficacy Trial
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

HIV INfections Clinical Trial
Updated: 12/31/1969
Connecting Youth and Young Adults to Optimize ART Adherence: YouTHrive Efficacy Trial
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Immunology / Infectious Diseases, Psychiatry / Psychology Clinical Trial
Updated: 12/31/1969
Reducing HIV Vulnerability Through A Multilevel Life Skills Intervention For Adolescent Men
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Immunology / Infectious Diseases, Neurology Clinical Trial
Updated: 12/31/1969
F 18 T807 PET (Positron Emission Tomograph )Scan for HIV Infected & Uninfected
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

HIV INfections Clinical Trial
Updated: 12/31/1969
Triggered Escalating Real-time Adherence (TERA) Intervention
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Click here to add this to my saved trials

Click here to add this to my saved trials

Immunology / Infectious Diseases, Psychiatry / Psychology Clinical Trial
Updated: 12/31/1969
Alcohol Research Consortium in HIV-Intervention Research Arm
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Primary Immune Deficiency Diseases (PIDD) Clinical Trial
Updated: 12/31/1969
Study of PlasmaCap IG in Adults and Children With PIDD
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Primary Immune Deficiency Diseases (PIDD) Clinical Trial
Updated: 12/31/1969
Study of PlasmaCap IG in Adults and Children With PIDD
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Hematology, Immunology / Infectious Diseases, Oncology, Rheumatology Clinical Trial
Updated: 12/31/1969
Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

Hematology, Immunology / Infectious Diseases, Oncology, Rheumatology Clinical Trial
Updated: 12/31/1969
Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

Hematology, Immunology / Infectious Diseases, Oncology, Rheumatology Clinical Trial
Updated: 12/31/1969
Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

Human Immunodeficiency Virus Clinical Trial
Updated: 10/24/2017
Prevention and Treatment Continuum for Youth at HIV Risk, Acutely Infected and With Established HIV Infection
Status: Enrolling
Updated: 10/24/2017
Click here to add this to my saved trials

Primary Immunodeficiency Diseases (PID) Clinical Trial
Updated: 12/31/1969
Efficacy, Safety, Tolerability, Immunogenicity and Pharmacokinetic Evaluation of HYQVIA in Pediatric PIDD Subjects
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Primary Immunodeficiency Diseases (PID) Clinical Trial
Updated: 12/31/1969
Efficacy, Safety, Tolerability, Immunogenicity and Pharmacokinetic Evaluation of HYQVIA in Pediatric PIDD Subjects
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Primary Immunodeficiency Diseases (PID) Clinical Trial
Updated: 12/31/1969
Efficacy, Safety, Tolerability, Immunogenicity and Pharmacokinetic Evaluation of HYQVIA in Pediatric PIDD Subjects
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Primary Immunodeficiency Diseases (PID) Clinical Trial
Updated: 12/31/1969
Efficacy, Safety, Tolerability, Immunogenicity and Pharmacokinetic Evaluation of HYQVIA in Pediatric PIDD Subjects
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Immunology / Infectious Diseases, Oncology Clinical Trial
Updated: 12/31/1969
Ibrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With HIV-Positive Stage II-IV Diffuse Large B-Cell Lymphomas
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Immunology / Infectious Diseases, Oncology Clinical Trial
Updated: 12/31/1969
Ibrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With HIV-Positive Stage II-IV Diffuse Large B-Cell Lymphomas
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
